Remembering Steve Couldwell, Zilico NED
Monday 12th October 2020
It is with great sadness that we share the news of the passing of our colleague and friend, Steven Couldwell. Steve has served as a non-executive director at Zilico Ltd for 5 years and has been integral to the ambition and success seen by the company since its commercial launch.
Our deepest condolences go to Steve’s wife and children and our thoughts extend to his wider family, friends and business colleagues who knew and respected him.
Always taking the time to stop and talk, whether business or social, Steve will be remembered fondly by all who knew him and greatly missed.
After completing a degree in Business Studies, Marketing from The University of Huddersfield, Steve went on to create a successful international track record in driving revenues and profit growth in both the medical device and CRO industries. Former roles included COO for Sanofi Biosurgery (Boston) and Vice President and General Manager of Covance Laboratories (Europe). Steve previously worked for Smith & Nephew for almost 10 years in a number of roles including President Orthopaedics (Europe) and Senior VP Innovation and Commercialisation for Smith & Nephew’s Advanced Wound Management division.
More recently Steve’s work was as Chief Executive Officer for Tissue Regenix Group, Zilico NED and as a business mentor to many.
We feel honoured to have known and worked with Steve and will all remember and value the significant contribution he has made as a business leader, mentor and friend.